STEM -- StemCells, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : STEM -- StemCells, Inc.

STEM 16.52

-7.1%

Nov 13 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (166)	1/10/1999 8:39:00 AM
From: Mike McFarland	Read Replies (1) of 805

and one more thing while I'm foaming at the mouth... I noticed that the news items on Yahoo are not complete, so I pulled this one off the cyto website: corporate-ir.net "By implementing these modifications to our implant procedure so quickly, Astra still expects to complete patient enrollment in this trial by the end of the year," stated Richard M. Rose, MD, President and Chief Executive Officer of CytoTherapeutics. "Furthermore, based on that timeframe, Astra could expect to complete its evaluation of the trial data in the first part of 1999." Okay, that's enough...apologies to the thread for repeating everything you probably aleady knew. --MM

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next